Skip to main content
Smart Investors Daily
AC

NYSE · ACH

Accendra Health, Inc.

Healthcare · Medical - Distribution

$0.47

Up+$0.02 (+3.35%)

Updated Oct 7, 2026, 6:36 AM

SID Score

2.8/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
187.18M
P/E ratio
-0.17
Dividend yield
0.00%
52-week range
$0.45 – $4.69
Volume
2.32M
Avg. volume
1.59M

Price performance · ACH

ACH price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 6, 2026

ACH closed at $0.47 after 21 trading sessions, down 57.63% for the selected period.

Last close
$0.47
Period change
-57.63%
Period low
$0.45
Period high
$1.12
Daily close
View OHLC price history
ACH OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 6, 2026$0.4639$0.5015$0.4421$0.46612.32M
Oct 5, 2026$0.51$0.5304$0.45$0.4511.56M
Oct 2, 2026$0.56$0.5745$0.50$0.50521.81M
Oct 1, 2026$0.5792$0.5938$0.5517$0.55781.66M
Sep 30, 2026$0.62$0.6346$0.5544$0.56272M
Sep 29, 2026$0.663$0.6631$0.5912$0.6122.03M
Sep 28, 2026$0.70$0.71$0.6396$0.651.47M
Sep 25, 2026$0.7332$0.7332$0.6636$0.7081.41M
Sep 24, 2026$0.7502$0.7598$0.7007$0.73321.31M
Sep 23, 2026$0.86$0.8635$0.75$0.75011.78M
Sep 22, 2026$0.875$0.8784$0.85$0.851.63M
Sep 21, 2026$0.91$0.92$0.86$0.87311.55M
Sep 18, 2026$1.04$1.04$0.8897$0.88973.88M
Sep 17, 2026$1.08$1.08$1.02$1.03691.33K
Sep 16, 2026$1.10$1.11$1.04$1.071.24M
Sep 15, 2026$1.13$1.13$1.055$1.11675.74K
Sep 14, 2026$1.04$1.145$1.03$1.12872.66K
Sep 11, 2026$1.11$1.11$1.05$1.081.03M
Sep 10, 2026$1.05$1.095$0.9601$1.081.09M
Sep 9, 2026$1.11$1.15$1.06$1.07796.04K
Sep 8, 2026$1.24$1.24$1.08$1.10810.84K

Latest ACH news

The latest Smart Investors Daily articles mentioning ACH.

ACH research

Overview

Company profile and research snapshot.

Company profile

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Hold
Average target
$12.39
Implied upside
—
Analysts
2
ACH recent ratings
DateFirmRatingTarget
Aug 13, 2026UBSNeutral—
Aug 11, 2026CitigroupNeutral—
Jul 24, 2026CitigroupBuy—
May 12, 2026BairdOutperform—
May 12, 2026CitigroupBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 17, 2026

Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth

RICHMOND, Va., September 17, 2026--Accendra Health, Inc. (NYSE: ACH) (the "Company") today named Kenneth Gardner-Smith as the Company’s next President and Chief Executive Officer. Gardner-Smith, who has served on the Company’s Board of Directors since March 2022, is expected to assume the role early in the fourth quarter 2026. He will succeed Edward A. Pesicka, who announced his intent to retire in August.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.